BackEsperion Therapeutics Overview

Esperion Therapeutics Operating Income

Operating Income for ESPR.

Quarterly Operating Income

$-6581000.00
↓ 70.22% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$83.72M
↓ 309.5% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin